The results illustrated that CHRDL1 was significantly correlative with T stage(P<0.001), N stage(P=0.008), pathologic stage(P=0.004), tumor status(P=0.023), TP53 status(P<0.001), gender(P=0.003) and age(P=0.003). This evidence concerns the gene TP53 and neoplasm.